Click Here to return To Results

 

A 24-Week, Randomized, Double-Blind Study of Donepezil in Moderate to Severe Alzheimer's Disease Neurol 57:613-620, Feldman,H.,et al, 2001 See this aricle in Pubmed Article Abstract These data suggest that donepezil's benefits extend into more advanced stages of AD than those previously investigated, with very good tolerability.

Related Tags

(click to filter results - removes previous filter) adverse drug reaction Alzheimer's disease Alzheimer's disease,treatment of dementia dementia,treatment of donepezil Mini Mental Status Examination psychological testing treatment of neurologic disorder

Click Here to return To Results